EBITDA: Income before interest, taxes, depreciation and amortization.
Aptose Biosciences, Inc. (APTOF) had EBITDA of $-6.82M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-7.04M |
|
-- |
|
-- |
|
$6.92M |
|
$-6.92M |
|
$-0.12M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-7.04M |
|
$-6.92M |
|
|
EBITDA |
$-6.82M |
2.55M |
|
2.55M |
|
$-2.76 |
|
$-2.76 |
|
| Balance Sheet Financials | |
$3.27M |
|
$0.02M |
|
$2.32M |
|
$5.59M |
|
$9.00M |
|
$10.96M |
|
$10.96M |
|
$19.96M |
|
$-14.37M |
|
$-14.37M |
|
$-14.37M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-8.74M |
|
-- |
|
$3.33M |
|
$6.71M |
|
$1.30M |
|
$-5.41M |
|
$0.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.36 |
|
-- |
|
-- |
|
-3.22 |
|
-0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.01% |
|
49.01% |
|
-125.97% |
|
206.60% |
|
$-5.63 |
|
$-3.42 |
|
$-3.42 |
|